Search

everythinglearnresearchcommunity

for

Search:↓

Collaboration and innovation are key to developing effective, safe hair loss treatments.

Metal nanoparticles show promise for treating hair loss but need more research to ensure safety.

Frontal fibrosing alopecia in Bogotá mainly affects postmenopausal women, with possible links to hormonal changes and sunscreen use.

Hair analysis can help diagnose adrenal disorders non-invasively.

The belief about hair shedding phases is likely incorrect and needs reevaluation.

Higher anxiety levels are linked to sexual dysfunction in women with PCOS.

Americans see hair transplants as valuable for treating hair loss and want them to be more affordable and tailored to each gender.

Low testosterone may indicate severe COVID-19 in men.

Gendered social factors, not just biology, contribute to sex differences in adverse drug events.

Eight blood metabolites are linked to causing allergic conjunctivitis, offering new ways to predict and treat it.

South African wild foods may help prevent cardiovascular disease.

Androgen use may increase the risk of stroke, but more research is needed.

The study concludes that regulating apoptosis could lead to new treatments for various skin and hair conditions.

Women have a higher DHT/testosterone ratio than men, possibly due to gut bacteria activity.

Genetic predictions of baldness in Europeans don't apply well to African men.

Lower hair copper and copper-to-zinc ratio are linked to more severe coronary artery disease.

Women with excessive hair growth tend to have shorter index and ring fingers compared to others.

Bioengineered skin models help reduce animal testing and advance research in cosmetics and skin disease.

Researchers found markers that can tell if hair has been bleached, which could improve hair test accuracy.

Insured Hispanics had more dermatology visits, while non-Hispanic Blacks and whites did not, with fewer visits for those with public insurance.

Androgenetic alopecia trials in the U.S. lack racial and ethnic diversity, limiting their applicability.

Clinical trials for hair loss in the USA show differences in participation among different races and ethnic groups.

Clinical trials for alopecia areata need better inclusion and retention of patients of color.

Hair loss (telogen effluvium) cases rose during the pandemic, especially in Hispanic and non-White groups, and were linked to other health issues and COVID-19.

The book provides a guide to cosmetic surgery for people with darker skin, covering various treatments and addressing their unique skin characteristics.

African American adults and non-White children experience more hair loss episodes than White patients with alopecia areata.

Dermatology datasets need more diversity in skin tones and ethnic representation.

Alopecia areata severity and symptoms vary by race and ethnicity.

Non-Hispanic Black and Hispanic female service members have the highest rates of hair loss.